
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy
Roger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 10, pp. e004867-e004867
Open Access | Times Cited: 23
Roger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 10, pp. e004867-e004867
Open Access | Times Cited: 23
Showing 23 citing articles:
Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer
Zepang Sun, Taojun Zhang, M. Usman Ahmad, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13
Zepang Sun, Taojun Zhang, M. Usman Ahmad, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10
Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
Ankit Mangla, Chanmi Lee, Matthew M. Mirsky, et al.
JAMA Oncology (2024) Vol. 10, Iss. 5, pp. 612-612
Open Access | Times Cited: 9
Ankit Mangla, Chanmi Lee, Matthew M. Mirsky, et al.
JAMA Oncology (2024) Vol. 10, Iss. 5, pp. 612-612
Open Access | Times Cited: 9
Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures
Song‐Bin Guo, Danqi Pan, Ning Su, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Song‐Bin Guo, Danqi Pan, Ning Su, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Prediction of immunotherapy response in nasopharyngeal carcinoma: a comparative study using MRI-based radiomics signature and programmed cell death ligand 1 expression score
Hui Mai, L Li, Xin Xin, et al.
European Radiology (2025)
Closed Access
Hui Mai, L Li, Xin Xin, et al.
European Radiology (2025)
Closed Access
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma
Alexandra Tompkins, Zane Gray, Rebekah Dadey, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e009568-e009568
Open Access
Alexandra Tompkins, Zane Gray, Rebekah Dadey, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e009568-e009568
Open Access
« Optimizing Imaging and Dose–Reponse in Radiotherapies » XVIe édition de l’atelier organisé par le réseau « Vectorisation, Imagerie, Radiothérapies » du Cancéropôle Grand-Ouest – 4–7 octobre 2023, Erquy, France
Françoise Léost, Vincent Potiron, Nicolas Lepareur, et al.
Bulletin du Cancer (2025)
Closed Access
Françoise Léost, Vincent Potiron, Nicolas Lepareur, et al.
Bulletin du Cancer (2025)
Closed Access
Radiomic-based approaches in the multi-metastatic setting: a quantitative review
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy
Jeremy McGale, Jakob Hama, Randy Yeh, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3065-3065
Open Access | Times Cited: 8
Jeremy McGale, Jakob Hama, Randy Yeh, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3065-3065
Open Access | Times Cited: 8
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
Ernesto Rossi, Luca Boldrini, Maria Grazia Maratta, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Ernesto Rossi, Luca Boldrini, Maria Grazia Maratta, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma
Ryan C. Augustin, Jason J. Luke
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 421-434
Closed Access | Times Cited: 1
Ryan C. Augustin, Jason J. Luke
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 421-434
Closed Access | Times Cited: 1
Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 116, pp. 102413-102413
Open Access | Times Cited: 1
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 116, pp. 102413-102413
Open Access | Times Cited: 1
Textural heterogeneity of liver lesions in CT imaging - comparison of colorectal and pancreatic metastases
Friedrich L. Pietsch, Florian Haag, Isabelle Ayx, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 12, pp. 4295-4306
Open Access | Times Cited: 1
Friedrich L. Pietsch, Florian Haag, Isabelle Ayx, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 12, pp. 4295-4306
Open Access | Times Cited: 1
Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations
Ahao Wu, Tengcheng Hu, Chao‐Sung Lai, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Ahao Wu, Tengcheng Hu, Chao‐Sung Lai, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Camila Gadens Zamboni, Ayca Dundar, Sanchay Jain, et al.
Deleted Journal (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Camila Gadens Zamboni, Ayca Dundar, Sanchay Jain, et al.
Deleted Journal (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma
Kangqiang Peng, Xiao Zhang, Zhongliang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Kangqiang Peng, Xiao Zhang, Zhongliang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Radiomic-Based Approaches in the Multi-metastatic Setting: a Quantitative Review
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective
Stefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 101-101
Open Access | Times Cited: 1
Stefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 101-101
Open Access | Times Cited: 1
Radiotherapy and immunotherapy combinations for cancer treatment: past, present and future
Silvia C. Formenti, Sana D. Karam, Fernanda G. Herrera, et al.
(2024)
Closed Access
Silvia C. Formenti, Sana D. Karam, Fernanda G. Herrera, et al.
(2024)
Closed Access
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
Stefania Crucitta, Federico Cucchiara, Riccardo Marconcini, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Stefania Crucitta, Federico Cucchiara, Riccardo Marconcini, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma
Alexandra Tompkins, Zane Gray, Rebekah Dadey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alexandra Tompkins, Zane Gray, Rebekah Dadey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
Mishal Mendiratta‐Lala, Issam El Naqa, Dawn Owen
Translational Cancer Research (2023) Vol. 12, Iss. 4, pp. 709-712
Open Access
Mishal Mendiratta‐Lala, Issam El Naqa, Dawn Owen
Translational Cancer Research (2023) Vol. 12, Iss. 4, pp. 709-712
Open Access
Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access